Fig. 3
From: Novel adjuvant nano-vaccine induced immune response against Acinetobacter baumannii
TLR-9 activation in human and mouse cells. A CpG ODN C274-mediated mouse TLR-9 activation in NF-kB Leeporter™—RAW 264.7 cells. B CpG ODN C274-mediated human TLR-9 activation in TLR-9/NF-kB Leeporter™—HEK293 cells. *p ≤ 0.05; **p ≤ 0.01, ***p ≤ 0.001. C The cytotoxicity of different formulations of nanovaccines after 24 h on RAW/HeK-293 cells. D Cell colonies of RAW/HeK-293 trated with CSNP, Free-pDNA-CSNP and pDNA-CpG-CSNP were stained with Giemsa. Experiments were performed in triplicate